Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

The Impact of Dose Rate on DNA Double-Strand Break Formation and Repair in Human Lymphocytes Exposed to Fast Neutron Irradiation.

Nair S, Engelbrecht M, Miles X, Ndimba R, Fisher R, du Plessis P, Bolcaen J, Nieto-Camero J, de Kock E, Vandevoorde C.

Int J Mol Sci. 2019 Oct 28;20(21). pii: E5350. doi: 10.3390/ijms20215350.

2.

A novel methodology to assess linear energy transfer and relative biological effectiveness in proton therapy using pairs of differently doped thermoluminescent detectors.

Parisi A, Chiriotti S, De Saint-Hubert M, Van Hoey O, Vandevoorde C, Beukes P, de Kock EA, Symons J, Camero JN, Slabbert J, Mégret P, Debrot E, Bolst D, Rosenfeld A, Vanhavere F.

Phys Med Biol. 2019 Apr 5;64(8):085005. doi: 10.1088/1361-6560/aaff20.

PMID:
30650402
3.

SOI microdosimetry and modified MKM for evaluation of relative biological effectiveness for a passive proton therapy radiation field.

Debrot E, Tran L, Chartier L, Bolst D, Guatelli S, Vandevoorde C, de Kock E, Beukes P, Symons J, Nieto-Camero J, Prokopovich DA, Chiriotti S, Parisi A, De Saint-Hubert M, Vanhavere F, Slabbert J, Rosenfeld AB.

Phys Med Biol. 2018 Nov 23;63(23):235007. doi: 10.1088/1361-6560/aaec2f.

PMID:
30468682
4.

MICRODOSIMETRIC MEASUREMENT OF SECONDARY RADIATION IN THE PASSIVE SCATTERED PROTON THERAPY ROOM OF iTHEMBA LABS USING A TISSUE-EQUIVALENT PROPORTIONAL COUNTER.

Chiriotti S, Parisi A, Vanhavere F, De Saint-Hubert M, Vandevoorde C, Slabbert J, Beukes P, de Kock E, Symons J.

Radiat Prot Dosimetry. 2018 Dec 1;182(2):252-257. doi: 10.1093/rpd/ncy056.

PMID:
29669096
5.

A temporal proteome dynamics study reveals the molecular basis of induced phenotypic resistance in Mycobacterium smegmatis at sub-lethal rifampicin concentrations.

Giddey AD, de Kock E, Nakedi KC, Garnett S, Nel AJ, Soares NC, Blackburn JM.

Sci Rep. 2017 Mar 6;7:43858. doi: 10.1038/srep43858.

6.

Mycobacterial proteomics: analysis of expressed proteomes and post-translational modifications to identify candidate virulence factors.

Calder B, Soares NC, de Kock E, Blackburn JM.

Expert Rev Proteomics. 2015 Feb;12(1):21-35. doi: 10.1586/14789450.2015.1007046. Review.

PMID:
25603863
7.

Positioning soundscape research and management.

Andringa TC, Weber M, Payne SR, Krijnders JD, Dixon MN, v d Linden R, de Kock EG, Lanser JJ.

J Acoust Soc Am. 2013 Oct;134(4):2739-47. doi: 10.1121/1.4819248.

PMID:
24116412
8.

Malignant salivary gland tumours: can fast neutron therapy results point the way to carbon ion therapy?

Stannard C, Vernimmen F, Carrara H, Jones D, Fredericks S, Hille J, de Kock E.

Radiother Oncol. 2013 Nov;109(2):262-8. doi: 10.1016/j.radonc.2013.08.013. Epub 2013 Sep 14.

PMID:
24044797
9.

Antimicrobial susceptibility of organisms causing community-acquired urinary tract infections in Gauteng Province, South Africa.

Lewis DA, Gumede LY, van der Hoven LA, de Gita GN, de Kock EJ, de Lange T, Maseko V, Kekana V, Smuts FP, Perovic O.

S Afr Med J. 2013 Mar 15;103(6):377-81. doi: 10.7196/samj.6722.

PMID:
23725955
10.

Evaluation of the safety and immunogenicity of two antigen concentrations of the Mtb72F/AS02(A) candidate tuberculosis vaccine in purified protein derivative-negative adults.

Leroux-Roels I, Leroux-Roels G, Ofori-Anyinam O, Moris P, De Kock E, Clement F, Dubois MC, Koutsoukos M, Demoitié MA, Cohen J, Ballou WR.

Clin Vaccine Immunol. 2010 Nov;17(11):1763-71. doi: 10.1128/CVI.00133-10. Epub 2010 Sep 22.

11.

The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans.

Von Eschen K, Morrison R, Braun M, Ofori-Anyinam O, De Kock E, Pavithran P, Koutsoukos M, Moris P, Cain D, Dubois MC, Cohen J, Ballou WR.

Hum Vaccin. 2009 Jul;5(7):475-82. Epub 2009 Jul 27.

PMID:
19587528
12.

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

Polhemus ME, Magill AJ, Cummings JF, Kester KE, Ockenhouse CF, Lanar DE, Dutta S, Barbosa A, Soisson L, Diggs CL, Robinson SA, Haynes JD, Stewart VA, Ware LA, Brando C, Krzych U, Bowden RA, Cohen JD, Dubois MC, Ofori-Anyinam O, De-Kock E, Ballou WR, Heppner DG Jr.

Vaccine. 2007 May 22;25(21):4203-12. Epub 2007 Mar 26.

PMID:
17442466
13.

Fluence correction factors in plastic phantoms for clinical proton beams.

Palmans H, Symons JE, Denis JM, de Kock EA, Jones DT, Vynckier S.

Phys Med Biol. 2002 Sep 7;47(17):3055-71.

PMID:
12361210
14.

Status report of the NAC particle therapy programme.

Jones DT, Schreuder AN, Symons JE, de Kock EA, Vernimmen FJ, Stannard CE, Wilson J, Schmitt G.

Strahlenther Onkol. 1999 Jun;175 Suppl 2:30-2.

PMID:
10394392
15.

The NAC proton treatment planning system.

Schreuder AN, Jones DT, Symons JE, De Kock EA, Hough JK, Wilson J, Vernimmen FJ, Schlegel W, Höss A, Lee M.

Strahlenther Onkol. 1999 Jun;175 Suppl 2:10-2.

PMID:
10394385
16.

Comments on 'The calibration of CT Hounsfield units for radiotherapy treatment planning'.

de Kock EA, Schreuder AN.

Phys Med Biol. 1996 Aug;41(8):1524-7. No abstract available.

PMID:
8858737
17.

Collective boson realization for the nuclear Sp(6) model.

de Kock EA, Geyer HB.

Phys Rev C Nucl Phys. 1991 Mar;43(3):1177-1186. No abstract available.

PMID:
9967159
18.

Interaction strengths in the interacting boson-fermion model.

de Kock EA, Geyer HB.

Phys Rev C Nucl Phys. 1988 Dec;38(6):2887-2894. No abstract available.

PMID:
9955132
19.

Cholelithiasis in children. A report of 3 cases.

de Bruin FA, de Kock EC, Schnetler PJ.

S Afr Med J. 1988 May 21;73(10):610.

PMID:
3287650
20.

Primary carcinoma of the distal duodenum.

de Villiers DR, de Kock EC, Stassen LW, Wilkinson OJ.

S Afr J Surg. 1973 Jun;11(2):61-5. No abstract available.

PMID:
4726431
21.

[The radiological diagnosis of supratentorial meningioma with special reference to cerebral arteriogaphy].

de Kock EC.

S Afr Med J. 1972 May 27;46(22):682-3. Afrikaans. No abstract available.

PMID:
5057326

Supplemental Content

Loading ...
Support Center